Gross profit increased 21.7%
Gross profit changed +21.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$90.6M→$110.3M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →LOVE financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed across a sign change
Net income changed +211.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 2 consecutive comparable moves in the opposite direction.
-$6.7M→$7.4M2 prior comparisons
Capital expenditure increased 51.4%
Capital expenditure changed +51.4% from the comparable as-filed period.
$4.3M→$6.6M3 prior comparisons
Free-cash-flow margin moved 589 bp higher
Free-cash-flow margin changed +589 basis points from the comparable as-filed period.
4.88%→10.77%2 prior comparisons
Operating cash-flow margin moved 726 bp higher
Operating cash-flow margin changed +726 basis points from the comparable as-filed period.
7.58%→14.84%2 prior comparisons
Stock-based compensation decreased 30.3%
Stock-based compensation changed -30.3% from the comparable as-filed period.
$3.3M→$2.3M2 prior comparisons
Capex / revenue moved 137 bp higher
Capex / revenue changed +137 basis points from the comparable as-filed period.
2.70%→4.07%2 prior comparisons
Total assets increased 9.2%
Total assets changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$493.7M→$539.0M4 prior comparisons
Revenue increased 0.4%
Revenue changed +0.4% from the comparable as-filed period.
$160.5M→$161.2M2 prior comparisons
Working capital / assets moved 112 bp higher
Working capital / assets changed +112 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
13.10%→14.22%4 prior comparisons
Research & development decreased 14.3%
Research & development changed -14.3% from the comparable as-filed period.
$2.1M→$1.8M2 prior comparisons
SBC / revenue moved 63 bp lower
SBC / revenue changed -63 basis points from the comparable as-filed period.
2.06%→1.43%2 prior comparisons
Shares outstanding decreased 1.3%
Shares outstanding changed -1.3% from the comparable as-filed period. The change ranks at the 29th percentile of 7 prior comparable changes.
14,610,309→14,423,4337 prior comparisons
Selling, general & administrative increased 0.3%
Selling, general & administrative changed +0.3% from the comparable as-filed period.
$72.1M→$72.3M2 prior comparisons
Current ratio decreased 2.9%
Current ratio changed -2.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
1.52→1.474 prior comparisons
R&D / revenue moved 19 bp lower
R&D / revenue changed -19 basis points from the comparable as-filed period.
1.31%→1.12%2 prior comparisons
Gross margin moved 166 bp lower
Gross margin changed -166 basis points from the comparable as-filed period.
53.75%→52.08%2 prior comparisons
Capex / revenue moved 256 bp lower
Capex / revenue changed -256 basis points from the comparable as-filed period.
6.20%→3.64%2 prior comparisons
Operating cash flow increased 14.6%
Operating cash flow changed +14.6% from the comparable as-filed period.
-$41.4M→-$35.4M2 prior comparisons
Capital expenditure decreased 41.4%
Capital expenditure changed -41.4% from the comparable as-filed period.
$8.6M→$5.0M2 prior comparisons
Free-cash-flow margin moved 688 bp higher
Free-cash-flow margin changed +688 basis points from the comparable as-filed period.
-36.10%→-29.22%2 prior comparisons
Operating cash-flow margin moved 432 bp higher
Operating cash-flow margin changed +432 basis points from the comparable as-filed period.
-29.90%→-25.58%2 prior comparisons
Current liabilities increased 13.5%
Current liabilities changed +13.5% from the comparable as-filed period.
$113.1M→$128.4M3 prior comparisons
Shares outstanding increased 0.6%
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 14th percentile of 7 prior comparable changes. This reverses 6 consecutive comparable moves in the opposite direction.
14,549,118→14,638,4187 prior comparisons
Revenue decreased 0.1%
Revenue changed -0.1% from the comparable as-filed period.
$138.4M→$138.2M2 prior comparisons
Total assets increased 3.6%
Total assets changed +3.6% from the comparable as-filed period.
$483.7M→$501.0M3 prior comparisons
Current assets increased 9.7%
Current assets changed +9.7% from the comparable as-filed period.
$181.5M→$199.0M3 prior comparisons
Working capital increased 3.3%
Working capital changed +3.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$68.4M→$70.6M3 prior comparisons
Net income decreased 2.3%
Net income changed -2.3% from the comparable as-filed period.
-$10.8M→-$11.1M2 prior comparisons
Stock-based compensation decreased 16.0%
Stock-based compensation changed -16.0% from the comparable as-filed period.
$2.5M→$2.1M2 prior comparisons
Gross profit decreased 3.2%
Gross profit changed -3.2% from the comparable as-filed period.
$74.4M→$72.0M2 prior comparisons
SBC / revenue moved 29 bp lower
SBC / revenue changed -29 basis points from the comparable as-filed period.
1.81%→1.52%2 prior comparisons
Selling, general & administrative increased 2.2%
Selling, general & administrative changed +2.2% from the comparable as-filed period.
$67.1M→$68.6M2 prior comparisons
Research & development decreased 4.5%
Research & development changed -4.5% from the comparable as-filed period.
$2.2M→$2.1M2 prior comparisons
Stockholders' equity increased 2.1%
Stockholders' equity changed +2.1% from the comparable as-filed period.
$201.2M→$205.5M2 prior comparisons
Working capital / assets moved 4 bp lower
Working capital / assets changed -4 basis points from the comparable as-filed period.
14.14%→14.10%3 prior comparisons
Current ratio decreased 3.4%
Current ratio changed -3.4% from the comparable as-filed period.
1.6→1.553 prior comparisons
R&D / revenue moved 7 bp lower
R&D / revenue changed -7 basis points from the comparable as-filed period.
1.59%→1.52%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.